APA (7th ed.) Citation

Lockwood, F., Lachaux, M., Harouki, N., Soulié, M., Nicol, L., Renet, S., . . . Mulder, P. (2025). Dual ETA‐ETB receptor antagonism improves metabolic syndrome‐induced heart failure with preserved ejection fraction. Fundamental & Clinical Pharmacology, 39(3), 1. https://doi.org/10.1111/fcp.70006

Chicago Style (17th ed.) Citation

Lockwood, Francesca, et al. "Dual ETA‐ETB Receptor Antagonism Improves Metabolic Syndrome‐induced Heart Failure with Preserved Ejection Fraction." Fundamental & Clinical Pharmacology 39, no. 3 (2025): 1. https://doi.org/10.1111/fcp.70006.

MLA (9th ed.) Citation

Lockwood, Francesca, et al. "Dual ETA‐ETB Receptor Antagonism Improves Metabolic Syndrome‐induced Heart Failure with Preserved Ejection Fraction." Fundamental & Clinical Pharmacology, vol. 39, no. 3, 2025, p. 1, https://doi.org/10.1111/fcp.70006.